Ultra-processed foods linked to rising premature deaths: Study reveals shocking details
A study analyzing data from nationally representative dietary surveys and mortality data from eight countries (Australia, Brazil, Canada, Chile, Colombia, Mexico, United Kingdom, and United States) shows that premature deaths attributable to consumption of ultraprocessed foods (UPFs) increase significantly according to their share in individuals' total energy intake. Also read | Are ultraprocessed foods hurting your health? Experts weigh in on risks and solutions
The new study, appearing in the American Journal of Preventive Medicine, published by Elsevier, reinforces the call for global action to reduce UPF consumption, supported by regulatory and fiscal policies that foster healthier environments.
UPFs are ready-to-eat-or-heat industrial formulations that are made with ingredients extracted from foods or synthesised in laboratories, with little or no whole foods in their composition.
These have gradually been replacing traditional foods and meals made from fresh and minimally processed ingredients.
Lead investigator of the study, Eduardo Augusto Fernandes Nilson, DSc, Oswaldo Cruz Foundation (Fiocruz), Brazil, says,
"UPFs affect health beyond the individual impact of high content of critical nutrients (sodium, trans fats, and sugar) because of the changes in the foods during industrial processing and the use of artificial ingredients, including colorants, artificial flavors and sweeteners, emulsifiers, and many other additives and processing aids, so assessing deaths from all-causes associated with UPF consumption allows an overall estimate of the effect of industrial food processing on health." Also read | Can ultra-processed foods raise cancer risk? Doctor explains the dangers
While previous studies focused on specific dietary risk factors instead of food patterns, the current study modeled data from nationally representative dietary surveys and mortality data from eight countries (Australia, Brazil, Canada, Chile, Colombia, Mexico, United Kingdom, and United States) to link dietary patterns, considering the extent and purpose of industrial food processing, to deaths from all causes.
High consumption of UPFs has been associated with 32 different diseases, including cardiovascular disease, obesity, diabetes, some types of cancer, and depression.
For the first time, this study has estimated the burden of UPF intake on premature deaths from all causes in different countries, showing that the attributable mortality is significant in all settings and that addressing UPF consumption should be a global public nutrition priority. Also read | The problematic American diet: Study reveals how ultra-processed foods are taking over the plates
Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
an hour ago
- NDTV
US Girl, 19, Dies After Trying Viral "Dusting" Challenge. All About This Deadly Social Media Trend
A 19-year-old girl in the US died on Sunday after taking part in a deadly social media trend called "dusting". According to The Independent, Renna O'Rourke from Arizona died after spending four days in the intensive care unit (ICU). Her parents said that she and her boyfriend ordered aerosol keyboard cleaner without their knowledge. After inhaling the keyboard cleaner, the teen went into cardiac arrest, spent a week unconscious in the ICU and then was declared brain dead. "She always said, 'I'm going to be famous, dad. Just you watch. I'm going to be famous,' and unfortunately, this is not under the most optimal of circumstances," the girls' father Aaron O'Rourke, said, per the outlet. "Dusting," also known as "chroming" or "huffing," is a viral trend that involves inhaling common household cleaners to get high for views online. The sensation reportedly causes brief euphoria but can cause instant, fatal damage, often due to heart failure, according to the Cleveland Clinic. According to a GoFundMe page, Renna was pronounced brain dead after purposely breathing in the cleaning spray. "There's no ID required. It's odourless. It's everything kids look for. They can afford it, they can get it, and it doesn't show in mom and dad's drug test," Renna's mother, Dana O'Rourke, said, per People. "She never regained consciousness," her mother added. Renna's parents described their late daughter as "vivacious and caring and loyal." Her father said that the 19-year-old loved to sing and lit up every room with her smile and laughter. Now, the O'Rourke family is working to honour Renna by spreading the word about the dangers of huffing for teens and parents. "Dig deep. Search their rooms. Don't trust - and that sounds horrible, but it could save their life," the mother said. They also started a GoFundMe page to cover the extensive medical bills, burial costs and therapy costs. Renna's father also plans to use the proceeds to spread awareness about the dangers of Huffing/Dusting, the practice of inhaling keyboard cleaner or similar. Notably, this trend has been around for years. In March 2024, an 11-year-old boy from the U.K. died after copying videos he had seen on social media of people sniffing or inhaling toxic substances. Figures cited by CNN also show an increase in the number of teens taking part in this deadly trend. From 2015 to 2022, the number of 12- to 17-year-old American adolescents using inhalants declined from 684,000 in 2015 to 554,000 in 2022, according to the US Substance Abuse and Mental Health Services Administration.
News18
3 hours ago
- News18
81,000 Vials, Rs 24 Crore In 3 Months: Weight Loss Drug Mounjaro Sales Triple As Patients Shift To Higher Dose
With three months since its launch in India, according to latest Pharmatrac data, Mounjaro clocked Rs 12.6 crore in sales in May 2025—a threefold increase from March In a sign of rising adoption, sales of Mounjaro—the breakthrough weight loss and type 2 diabetes drug—have nearly tripled in the last two months, data shows. American drugmaker Eli Lilly launched Mounjaro in India on March 20, triggering immediate frenzy, especially among those looking to achieve weight loss and glucose control. Doctors told News18 they were flooded with requests from patients eager to start Mounjaro or learn more about its benefits. With three months since its launch in India, according to latest Pharmatrac data, Mounjaro clocked Rs 12.6 crore in sales in May 2025—a threefold increase from March. The higher dosage form of five milligram, in particular, more than doubled in value and quantity sales between April and May, indicating a strong trend of patient progression to the next stage of treatment. As per the medical protocol, patients start with lower dosage of 2.5 milligram weekly dose and upgrade to 5 milligram after four weeks. 'This clinical shift is clearly reflected in market numbers. Five mg pack sales jumped from Rs 3.08 crore in April to Rs 7.53 crore in May, while unit sales rose from over 9,300 to over 22,900," Sheetal Sapale, vice-president (commercial), Pharmatrac, told News18. 'Looking at these trends and the acceptance of this therapy—by physicians as well as patients—along with the affordable pricing of Rs 18,000 to Rs 22,000 per month dosage indicates a definite pick up in consumption." The total market for Mounjaro has reached Rs 23.94 crore over the past three months, selling more than 81,000 vials of the drug—signalling growing adoption in diabetes care protocols. According to Dr Anoop Misra, chairman, Fortis C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, clinical use of Mounjaro in India closely reflects the trends observed in the data. 'A substantial number of patients are being initiated at 2.5 mg, with a timely escalation to 5 mg in line with recommended protocols. This pattern suggests good tolerability and early clinical efficacy in glycemic control and weight reduction." Misra told News18: 'With growing familiarity and broader access, increased use of higher doses (7.5 mg and above) is likely, especially in patients requiring enhanced metabolic outcomes." The injectable drug is approved by India's apex drug regulatory body, Central Drugs Standard Control Organisation (CDSCO). Mounjaro is a once-weekly injection priced at Rs 4,375 for a 5 mg vial and Rs 3,500 for a 2.5 mg vial, making the monthly expenditure around Rs 14,000-Rs 17,500. The drug is claimed to be 80 per cent cheaper than in the United States. Entry-Level Dosage Sales Plateau Mounjaro, the brand name for Tirzepatide, a once-weekly injectable, is a first-in-class medication that combines the effects of two naturally occurring hormones: GIP (Gastric Inhibitory Polypeptide) and GLP-1 (Glucagon-Like Peptide-1). Data shows that the 2.5mg dose of Mounjaro—generally prescribed as the starting regimen for type 2 diabetes patients or those looking to shed weight—has shown signs of 'plateauing growth". This trend confirms a gradual shift to higher doses. The sales value for the 2.5 mg injection rose marginally from Rs 4.80 crore in April to Rs 5.08 crore in May, after a steeper increase from Rs 1.42 crore in March. The data shows that the unit sales also reflect this trend, increasing from 5,400 in March to 18,270 in April, but only marginally to 19,350 in May. While the 2.5 mg variant remains essential for entry-level patient initiation, its month-on-month growth may continue to taper off as the patient base matures and advances to the next phase of dosing.
Time of India
5 hours ago
- Time of India
5 side effects of walking too much and what to do about it
Walking has numerous health advantages and is a low-impact aerobic activity. Simple and no-equipment workout: walking can be one of the best ways to stay in shape. It's a fantastic method to control weight, elevate mood, and strengthen the heart. However, you can overdo it, just like with other activities. You may be wondering how much walking is too much if you now walk for exercise or intend to start. The response is contingent upon multiple circumstances. The following information will help you determine how much walking is too much for you. How many steps should you take each day? Even while 10,000 steps is an often mentioned goal, your daily step count will vary depending on your age, degree of fitness, and health objectives. Aiming for 8,000–10,000 steps a day is generally a decent baseline, although even fewer steps can have positive health effects. Long-distance walking has advantages that can make the effort worthwhile. Increasing your step count may help you live a longer life in addition to reducing your chances of type 2 diabetes and boosting heart health. Walking more steps per day was linked to a lower risk of death from all causes than walking fewer steps per day, according to a 2020 study of nearly 4,800 American people. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Forget Furosemide, Use This Household Item To Help Drain Edema Fluid WellnessGuide Learn more Undo How much walking is too much walking? 'Too much walking' is a relative concept. Your degree of fitness, experience, and general health all play a role. After a vigorous 30-minute walk, a novice hiker may feel pain, but an experienced hiker may go painlessly for hours. There's no one-size-fits-all solution, but it's important to pay attention to your body. Perhaps you follow the "hot girl walk" fad on TikTok, or perhaps you've embraced the urban hiking movement, which for some people is walking up to 10 to 15 kilometers per day. Walking, or any exercise for that matter, has no "maximal" limit. Side effects of walking too much Old pain flare up It's common for old ailments, such as a hurting knee, to recur. Increased risk of injury: Overtraining soreness can result in poor walking form and posture, which can raise the risk of injury. Additionally, compared to when they are properly rested, sore or wounded joints are more vulnerable to an unexpected, serious injury. Calluses and blisters Calluses and blisters may develop on or around your feet if you've been walking a lot lately. Although they are typical with new shoes, recurrent calluses or blisters may be a sign of poor gait or poorly fitting footwear. Recurring fatigue Your capacity to exercise is impacted by overtraining. Overtrainers become tired easily. You might have heavy breathing and find it difficult to talk in complete words, even at a reduced speed. At this point, you ought to pause and consult a medical professional to help direct your recuperation. Swelling in limbs Swelling and pain in feet indicate that a recent walk was either too long or too strenuous. You can experience a decline in your performance and heavy, tight muscles if you walk consistently for a longer duration. Mood swings While walking may be a mood booster, walking too much may generate anxiety. Psychological symptoms like depression and anger may arise if you keep walking too much or too intensely. How to maintain walking routine within a healthy limit Starting with no more than 15 minutes of walking at a moderate pace is an excellent technique for beginners. You'll know you're at the proper pace when you can talk in complete sentences without breathing significantly. Next, increase the amount of time you spend walking each week by a few minutes until you reach 30 minutes of vigorous walking. You should be breathing through your lips instead of your nose, but you should be able to speak in complete phrases. Try to walk at least three days a week to reap the full benefits of walking. You should exercise in other ways besides walking, such as strength training, flexibility training, and balancing exercises. With all its benefits, there are some potential disadvantages too One step to a healthier you—join Times Health+ Yoga and feel the change
